DDOST p.Val299Met
c.895G>A · VCV3625374
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1715 | likely benign |
|---|---|---|
| REVEL | 0.553 | indeterminate |
| SaProt | LLR -10.82 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 0.92 | unconstrained · MANE · 8,968 bp · p 0.046 · regional, not allelic |
| Overall | ||
| CADD | 28.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V316M vs ClinVar V299M) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,827 |
| European (non-Finnish)grpmax | 0.00271% | 36,866 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DDOST
- Protein
- p.Val299Met
- Coding
- c.895G>A
- MANE Select
- NM_005216
- Type
- single nucleotide variant
- Location
- chr1:20653674 (GRCh38)
- Gene constraint
- LOEUF 0.747 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 89.27 · 6 PDB
- Residue 299
- an α-helix
Disease context
DDOST-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor DDOST-CDG (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- DDOST p.Val299= Uncertain significance ★ same residue
- DDOST p.Gln215His Pathogenic/Likely pathogenic ★★ ⚠ same condition
- DDOST c.-18T>G Uncertain significance ★★ ⚠ same condition
- DDOST p.Ala11Val Uncertain significance ★★ ⚠ same condition
- DDOST p.Ala219Val Uncertain significance ★★ ⚠ same condition
- DDOST p.Ala232Ser Uncertain significance ★★ ⚠ same condition
- DDOST p.Ala415Thr Uncertain significance ★★ ⚠ same condition
- DDOST p.Arg237His Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ddost-p-val299met (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown